{"recordsFiltered":49251,"recordsTotal":49251,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=sponsor__name&start=34800","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=sponsor__name&start=34200","results":[{"registry_id":"NCT06799741","publication_url":"https://clinicaltrials.gov/study/NCT06799741","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Safety and Efficacy of 3 Dose Levels of AV-1 in Healthy Adults Challenged With a Controlled Human Infection Strain of DENV-3","has_exemption":false,"start_date":"2025-01-07","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"AbViro LLC","sponsor_slug":"abviro-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06850363","publication_url":"https://clinicaltrials.gov/study/NCT06850363","title":"ExaStim Upper Limb Home Use Clinical Validation Study","has_exemption":false,"start_date":"2025-03-17","completion_date":"2026-03-11","has_results":false,"results_due":false,"sponsor_name":"Niche Biomedical, Inc. dba ANEUVO","sponsor_slug":"niche-biomedical-inc-dba-aneuvo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630325","publication_url":"https://clinicaltrials.gov/study/NCT06630325","title":"Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART): Adaptive Clinical Treatment (ACT)","has_exemption":false,"start_date":"2025-06-24","completion_date":"2026-03-11","has_results":true,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03360721","publication_url":"https://clinicaltrials.gov/study/NCT03360721","title":"A Phase 2, Study of Apalutamide and Abiraterone Acetate in Castration-Resistant Metastatic Prostate Cancer Patients Evaluating a Predetermined Biomarker Signature","has_exemption":false,"start_date":"2018-03-06","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03643510","publication_url":"https://clinicaltrials.gov/study/NCT03643510","title":"Phase II Study of Fulvestrant in Combination With Abemaciclib in Hormone Receptor Positive Adenocarcinoma of Endometrium","has_exemption":false,"start_date":"2018-08-21","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05352672","publication_url":"https://clinicaltrials.gov/study/NCT05352672","title":"A Phase 3 Trial of Fianlimab (REGN3767, Anti-LAG-3) + Cemiplimab Versus Pembrolizumab in Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma","has_exemption":false,"start_date":"2022-07-14","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06036836","publication_url":"https://clinicaltrials.gov/study/NCT06036836","title":"A Multicenter, Randomized, Double-Blind, Phase 2, Basket Study of MK-4280A, a Coformulation of Favezelimab (MK-4280) With Pembrolizumab (MK-3475) in Selected Solid Tumors (KeyForm-010)","has_exemption":false,"start_date":"2023-09-29","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06425159","publication_url":"https://clinicaltrials.gov/study/NCT06425159","title":"A Phase 2/3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 as Adjunctive Therapy in Subjects With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures, With Open-label Extension","has_exemption":false,"start_date":"2024-06-20","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Biohaven Therapeutics Ltd.","sponsor_slug":"biohaven-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06513182","publication_url":"https://clinicaltrials.gov/study/NCT06513182","title":"Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty? A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-06-21","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06698042","publication_url":"https://clinicaltrials.gov/study/NCT06698042","title":"A Phase 3 Randomized, Open-label Clinical Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Versus Intravenous Pembrolizumab, in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer With PD-L1 TPS 50% or Greater","has_exemption":false,"start_date":"2024-11-21","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06638671","publication_url":"https://clinicaltrials.gov/study/NCT06638671","title":"Short-Term Metformin Use in Young, Healthy Adults: Impacts on the Blood Lactate Response to Exercise and Time-to-exhaustion in a Placebo-controlled, Crossover Study","has_exemption":false,"start_date":"2025-01-31","completion_date":"2026-03-12","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02627508","publication_url":"https://clinicaltrials.gov/study/NCT02627508","title":"Randomized Controlled Pilot Trial of Pregnenolone in Autism","has_exemption":false,"start_date":"2016-01-29","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05393258","publication_url":"https://clinicaltrials.gov/study/NCT05393258","title":"A Pilot Study of Temporally-modulated Pulsed Radiation Therapy to Reirradiate Recurrent IDH-mutant Gliomas After Prior External Beam Radiation Therapy","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05815784","publication_url":"https://clinicaltrials.gov/study/NCT05815784","title":"Myopia Control in the Pediatric Population: a Comparison of MiSight, Naturalvue Multifocal, and Atropine 0.05%","has_exemption":false,"start_date":"2023-05-02","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","sponsor_slug":"ann-robert-h-lurie-childrens-hospital-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06140836","publication_url":"https://clinicaltrials.gov/study/NCT06140836","title":"Randomized, Open-label, Multicenter, Phase 3 Trial of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)","has_exemption":false,"start_date":"2023-12-21","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06159777","publication_url":"https://clinicaltrials.gov/study/NCT06159777","title":"Pre- and Post-operative Compared to Post-operative Only Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery","has_exemption":false,"start_date":"2024-06-05","completion_date":"2026-03-13","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05721677","publication_url":"https://clinicaltrials.gov/study/NCT05721677","title":"The Impact of Central-line Exit-site Sealing With 2-octyl Cyanoacrylate Adhesive on CLABSI in Pediatric Cardiac Intensive Care Unit","has_exemption":false,"start_date":"2023-03-15","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"Rabin Medical Center","sponsor_slug":"rabin-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05967585","publication_url":"https://clinicaltrials.gov/study/NCT05967585","title":"Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics","has_exemption":false,"start_date":"2023-08-04","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06052969","publication_url":"https://clinicaltrials.gov/study/NCT06052969","title":"PERFUSION AIS - Pulse Endovascular ReperFUSION for Acute Ischemic Stroke: An Early Feasibility Clinical Study","has_exemption":false,"start_date":"2023-10-01","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"Euphrates Vascular, Inc.","sponsor_slug":"euphrates-vascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06729255","publication_url":"https://clinicaltrials.gov/study/NCT06729255","title":"A Single Academic Center, Prospective Cohort With Retrospective Loss-of-resistance Comparator, Proof of Concept Study to Evaluate the Safety, Efficacy, and Usability of the EpiZact Device for Parturients Undergoing Epidural Labor Analgesia","has_exemption":false,"start_date":"2025-03-15","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919081","publication_url":"https://clinicaltrials.gov/study/NCT06919081","title":"Phase II Study of the Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease","has_exemption":false,"start_date":"2025-08-01","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07140640","publication_url":"https://clinicaltrials.gov/study/NCT07140640","title":"Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.","has_exemption":false,"start_date":"2025-09-15","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"Aswan University","sponsor_slug":"aswan-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07275424","publication_url":"https://clinicaltrials.gov/study/NCT07275424","title":"Open-Label, Single-Arm Phase 2a Pilot Study to Evaluate the Safety and Tolerability of a Daily Subcutaneous Dose of Elamipretide in Older Adults","has_exemption":false,"start_date":"2025-11-26","completion_date":"2026-03-15","has_results":false,"results_due":false,"sponsor_name":"David Marcinek","sponsor_slug":"david-marcinek","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03436654","publication_url":"https://clinicaltrials.gov/study/NCT03436654","title":"Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma","has_exemption":false,"start_date":"2018-06-21","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03997123","publication_url":"https://clinicaltrials.gov/study/NCT03997123","title":"A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib/+Paclitaxel vs Placebo+Paclitaxel as First-line Treatment for Patients With Locally Advanced (Inoperable) or Metastatic TNBC.","has_exemption":false,"start_date":"2019-06-25","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04856085","publication_url":"https://clinicaltrials.gov/study/NCT04856085","title":"A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection","has_exemption":false,"start_date":"2021-07-11","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Vir Biotechnology, Inc.","sponsor_slug":"vir-biotechnology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05803421","publication_url":"https://clinicaltrials.gov/study/NCT05803421","title":"A Phase 3, Open-Label Study of Once Daily LY3502970 Compared With Insulin Glargine in Adult Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk","has_exemption":false,"start_date":"2023-04-03","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05994937","publication_url":"https://clinicaltrials.gov/study/NCT05994937","title":"Glycemic and Cardiometabolic Biomarker Improvements Associated With Reduction in Air Pollution Exposure","has_exemption":false,"start_date":"2023-12-26","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05962606","publication_url":"https://clinicaltrials.gov/study/NCT05962606","title":"An Exploratory, Multi-Centre, Interventional, Prospective, Randomised, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of AON-D21 in Patients With Severe Community-Acquired Pneumonia.","has_exemption":false,"start_date":"2024-02-02","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Aptarion Biotech AG","sponsor_slug":"aptarion-biotech-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06159790","publication_url":"https://clinicaltrials.gov/study/NCT06159790","title":"A Randomized, Double-blind, Parallel-group Study to Compare Efficacy, Safety, and Immunogenicity of GME751 (Proposed Pembrolizumab Biosimilar) and EU-authorized Keytruda® in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2024-04-29","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Sandoz","sponsor_slug":"sandoz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06613685","publication_url":"https://clinicaltrials.gov/study/NCT06613685","title":"An Operationally Seamless Phase 2/3, Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination With GS-4182 Versus Biktarvy in Treatment-Naive People With HIV-1","has_exemption":false,"start_date":"2024-10-21","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06911424","publication_url":"https://clinicaltrials.gov/study/NCT06911424","title":"A Phase 3 Randomized, Multi-Center, Placebo-Controlled, Masked Study to Evaluate the Clinical Efficacy and Safety of Fusidic Acid 1% Viscous Topical Antibiotic Eye Drops for the Treatment of Suspected Bacterial Conjunctivitis","has_exemption":false,"start_date":"2025-03-21","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Baxis Pharmaceuticals, Inc.","sponsor_slug":"baxis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287423","publication_url":"https://clinicaltrials.gov/study/NCT07287423","title":"LEadless Advanced Pacing 2 Chronic Early Feasibility Study","has_exemption":false,"start_date":"2025-12-13","completion_date":"2026-03-16","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04155034","publication_url":"https://clinicaltrials.gov/study/NCT04155034","title":"MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)","has_exemption":false,"start_date":"2020-05-04","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05490446","publication_url":"https://clinicaltrials.gov/study/NCT05490446","title":"A Phase 2a/2b, Open-label, Proof of Concept (Phase 2a) and Open-label (Phase 2b), Multicenter, Efficacy, and Safety Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes","has_exemption":false,"start_date":"2022-11-07","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"Agios Pharmaceuticals, Inc.","sponsor_slug":"agios-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05223036","publication_url":"https://clinicaltrials.gov/study/NCT05223036","title":"A Phase IIa, Placebo-Controlled, Randomized Study of Daily Obeticholic Acid (OCA) to Reduce Intestinal Polyp Burden in Familial Adenomatous Polyposis (FAP)","has_exemption":false,"start_date":"2023-01-19","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06113471","publication_url":"https://clinicaltrials.gov/study/NCT06113471","title":"A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo","has_exemption":false,"start_date":"2023-11-27","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05643638","publication_url":"https://clinicaltrials.gov/study/NCT05643638","title":"A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of CYP-001 in Combination With Corticosteroids vs Corticosteroids Alone for the Treatment of High-Risk Acute Graft Versus Host Disease","has_exemption":false,"start_date":"2024-03-04","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"Cynata Therapeutics Limited","sponsor_slug":"cynata-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05513027","publication_url":"https://clinicaltrials.gov/study/NCT05513027","title":"A Prospective Study of the Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection","has_exemption":false,"start_date":"2024-03-06","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06336343","publication_url":"https://clinicaltrials.gov/study/NCT06336343","title":"A Study to Evaluate the Safety and Efficacy of Bimekizumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17 or IL-23 Therapies","has_exemption":false,"start_date":"2024-06-03","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07542548","publication_url":"https://clinicaltrials.gov/study/NCT07542548","title":"D-Cycloserine for Serine Palmitoyltransferase Inhibition: Treatment of a Single Patient With a Complex Hereditary Spastic Paraplegia Due to a De Novo Variant in the SPTSSA Gene","has_exemption":false,"start_date":"2024-07-10","completion_date":"2026-03-17","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03217188","publication_url":"https://clinicaltrials.gov/study/NCT03217188","title":"A Phase II Study of Proton Re-Irradiation for Recurrent Head and Neck Cancer","has_exemption":false,"start_date":"2017-07-10","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03961347","publication_url":"https://clinicaltrials.gov/study/NCT03961347","title":"Evaluation of Safety, Tolerability and Immunological Responses to Lactobacillus Johnsonii N6.2 Supplementation in Adults With Diabetes Type 1","has_exemption":false,"start_date":"2020-02-01","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04901169","publication_url":"https://clinicaltrials.gov/study/NCT04901169","title":"Angiotensin II in Liver Transplantation (AngLT-1): A Pilot Randomized Controlled Trial","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05510115","publication_url":"https://clinicaltrials.gov/study/NCT05510115","title":"Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease","has_exemption":false,"start_date":"2022-11-18","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05747924","publication_url":"https://clinicaltrials.gov/study/NCT05747924","title":"A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)","has_exemption":false,"start_date":"2023-04-04","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"Avidity Biosciences, Inc.","sponsor_slug":"avidity-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06188559","publication_url":"https://clinicaltrials.gov/study/NCT06188559","title":"An Open-label, Multicenter, Phase 2 Dose Optimization and Expansion Study to Evaluate the Safety and Efficacy of BB-1701, an Anti-human Epidermal Growth Factor Receptor 2 (Anti-HER2) Antibody-drug Conjugate (ADC), in Previously Treated Subjects With HER2-positive or HER2-low Unresectable or Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-04-10","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"Eisai Inc.","sponsor_slug":"eisai-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06423781","publication_url":"https://clinicaltrials.gov/study/NCT06423781","title":"A Phase 2, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of BHV-7000 in Treatment of Major Depressive Disorder (MDD)","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"Biohaven Therapeutics Ltd.","sponsor_slug":"biohaven-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07613892","publication_url":"https://clinicaltrials.gov/study/NCT07613892","title":"Post Operative Skin Approximation With Cyanoacrylate Based Wound Closure Adhesives","has_exemption":false,"start_date":"2025-04-02","completion_date":"2026-03-18","has_results":false,"results_due":false,"sponsor_name":"Medline Industries","sponsor_slug":"medline-industries","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02816021","publication_url":"https://clinicaltrials.gov/study/NCT02816021","title":"Phase II Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma","has_exemption":false,"start_date":"2017-02-14","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03786081","publication_url":"https://clinicaltrials.gov/study/NCT03786081","title":"A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer","has_exemption":false,"start_date":"2019-02-27","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03805789","publication_url":"https://clinicaltrials.gov/study/NCT03805789","title":"A Phase 2/3, Multicenter, randOmized, Double-blind, Placebo-controlled, stUdy to evaLuate the Safety and Efficacy of Alpha-1 AntiTrypsin for the prEvention of Graft-versus-host Disease in Patients Receiving Hematopoietic Cell Transplant (MODULAATE Study)","has_exemption":false,"start_date":"2019-03-27","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"CSL Behring","sponsor_slug":"csl-behring","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05304767","publication_url":"https://clinicaltrials.gov/study/NCT05304767","title":"An Open-label Extension Study to Assess the Long-term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia","has_exemption":false,"start_date":"2022-03-07","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","sponsor_slug":"karuna-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05268289","publication_url":"https://clinicaltrials.gov/study/NCT05268289","title":"An Adaptive, Randomized, Double-blind, Dose Exploration, Parallel Group, Placebo Controlled, Multicenter Phase 2 Trial to Evaluate the Efficacy, Safety and Tolerability of LNP023 in Combination With Standard-of-care With and Without Oral Corticosteroids in Patients With Active Lupus Nephritis Class III-IV, +/- V","has_exemption":false,"start_date":"2022-08-10","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06333860","publication_url":"https://clinicaltrials.gov/study/NCT06333860","title":"A Phase 4 Multicenter, Randomized, Open-label, Efficacy Assessor Blinded Study of Risankizumab Compared to Deucravacitinib for the Treatment of Adult Subjects With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy","has_exemption":false,"start_date":"2024-05-10","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07193563","publication_url":"https://clinicaltrials.gov/study/NCT07193563","title":"The ENCalmSocial Trial: A Randomized, Double-Blind, Placebo-Controlled Monotherapy Trial to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder","has_exemption":false,"start_date":"2025-09-05","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"Engrail Therapeutics INC","sponsor_slug":"engrail-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07168148","publication_url":"https://clinicaltrials.gov/study/NCT07168148","title":"Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants","has_exemption":false,"start_date":"2025-11-10","completion_date":"2026-03-19","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03485209","publication_url":"https://clinicaltrials.gov/study/NCT03485209","title":"Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors","has_exemption":false,"start_date":"2018-06-25","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04817254","publication_url":"https://clinicaltrials.gov/study/NCT04817254","title":"Phase II Trial Evaluating the Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma","has_exemption":false,"start_date":"2021-12-08","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05348447","publication_url":"https://clinicaltrials.gov/study/NCT05348447","title":"Randomized Trial of Intercostal Nerve Cryotherapy in Patients Undergoing Minimally Invasive Pulmonary Resection","has_exemption":false,"start_date":"2022-04-21","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","sponsor_slug":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06439602","publication_url":"https://clinicaltrials.gov/study/NCT06439602","title":"A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants With Gout","has_exemption":false,"start_date":"2024-06-26","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"Arthrosi Therapeutics","sponsor_slug":"arthrosi-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06716216","publication_url":"https://clinicaltrials.gov/study/NCT06716216","title":"A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of BGM0504 Versus Semaglutide Once Weekly As Add-on Therapy to Metformin And/or Sulfonylureas in Patients with Type 2 Diabetes","has_exemption":false,"start_date":"2024-11-29","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"BrightGene Bio-Medical Technology Co., Ltd.","sponsor_slug":"brightgene-bio-medical-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06783621","publication_url":"https://clinicaltrials.gov/study/NCT06783621","title":"US HARMONY in DIVERSITY: A Prospective, Open-label Study to Evaluate Subject Satisfaction With the Overall Face and Neck Appearance After Combined Treatment","has_exemption":false,"start_date":"2025-01-16","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06887933","publication_url":"https://clinicaltrials.gov/study/NCT06887933","title":"A Prospective, Multicentre, Open Labelled, Single Arm Phase-IV Clinical Trial of Niraparib in Indian Patients With Advanced or Relapsed Ovarian Cancer Who Are in Complete or Partial Response Following Platinum Based Chemotherapy","has_exemption":false,"start_date":"2025-04-22","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06831084","publication_url":"https://clinicaltrials.gov/study/NCT06831084","title":"Acute Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer Patients With the Use of Silver-Plated Technology: A Single Arm Phase II Trial","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"Parul Barry","sponsor_slug":"parul-barry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07346261","publication_url":"https://clinicaltrials.gov/study/NCT07346261","title":"Impact of Digital High-Intensity Respiratory Muscle Training on Ventilatory Function and Functional Capacity in Patients With COPD","has_exemption":false,"start_date":"2026-01-20","completion_date":"2026-03-20","has_results":false,"results_due":false,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05930418","publication_url":"https://clinicaltrials.gov/study/NCT05930418","title":"Cardiovascular Magnetic Resonance Prognosticators In Pediatric Oncology Patients With Sepsis: A Priority Pilot Study","has_exemption":false,"start_date":"2023-05-20","completion_date":"2026-03-21","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06523621","publication_url":"https://clinicaltrials.gov/study/NCT06523621","title":"Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Response To Idecabtagene Vicleucel","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-03-21","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04569747","publication_url":"https://clinicaltrials.gov/study/NCT04569747","title":"20-347 NCT Number Title A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (ADEPT)","has_exemption":false,"start_date":"2021-01-11","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06305793","publication_url":"https://clinicaltrials.gov/study/NCT06305793","title":"RECOVER-AUTONOMIC (IVIG): Randomized Trial of the Effect of IVIG Versus Placebo on Long COVID Symptoms","has_exemption":false,"start_date":"2024-03-11","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"Kanecia Obie Zimmerman","sponsor_slug":"kanecia-obie-zimmerman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06303570","publication_url":"https://clinicaltrials.gov/study/NCT06303570","title":"A Single-Blind, Placebo-Control, Randomized Phase 2 Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas","has_exemption":false,"start_date":"2024-11-27","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"Caliway Biopharmaceuticals Co., Ltd.","sponsor_slug":"caliway-biopharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06710795","publication_url":"https://clinicaltrials.gov/study/NCT06710795","title":"AFFIX: Evaluation of the performAnce and saFety of the MaxTack™ Motorized FIXation Device in Subjects Undergoing Repair of Ventral Hernia by Minimally Invasive Surgery","has_exemption":false,"start_date":"2025-06-16","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"Medtronic - MITG","sponsor_slug":"medtronic-mitg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011797","publication_url":"https://clinicaltrials.gov/study/NCT07011797","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants","has_exemption":false,"start_date":"2025-06-17","completion_date":"2026-03-23","has_results":false,"results_due":false,"sponsor_name":"Corxel Pharmaceuticals","sponsor_slug":"corxel-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03364114","publication_url":"https://clinicaltrials.gov/study/NCT03364114","title":"Interscope Endorotor® Mucosal Resection System With Continued Ablative Therapy In Subjects With Refractory Dysplastic Barrett's Esophagus","has_exemption":false,"start_date":"2018-02-09","completion_date":"2026-03-24","has_results":false,"results_due":false,"sponsor_name":"Interscope, Inc.","sponsor_slug":"interscope-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03328026","publication_url":"https://clinicaltrials.gov/study/NCT03328026","title":"A Phase I/II Study of the SV-BR-1-GM Regimen in Metastatic or Locally Recurrent Breast Cancer Patients in Combination With Retifanlimab","has_exemption":false,"start_date":"2018-03-16","completion_date":"2026-03-24","has_results":false,"results_due":false,"sponsor_name":"BriaCell Therapeutics Corporation","sponsor_slug":"briacell-therapeutics-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06404099","publication_url":"https://clinicaltrials.gov/study/NCT06404099","title":"RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)","has_exemption":false,"start_date":"2024-08-12","completion_date":"2026-03-24","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727058","publication_url":"https://clinicaltrials.gov/study/NCT06727058","title":"A Phase 1/2, Randomized, Modified Double-blind, Placebo-controlled, Multi-center, Dose Escalating Study to Evaluate the Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older","has_exemption":false,"start_date":"2024-12-09","completion_date":"2026-03-24","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02625480","publication_url":"https://clinicaltrials.gov/study/NCT02625480","title":"A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ZUMA-4)","has_exemption":false,"start_date":"2016-02-01","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Kite, A Gilead Company","sponsor_slug":"kite-a-gilead-company","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05867602","publication_url":"https://clinicaltrials.gov/study/NCT05867602","title":"Clinical Efficacy of High-dose Albumin Administration Versus Standard Dose in Patients With Advanced Cirrhosis: Open Label Randomized Clinical Trial","has_exemption":false,"start_date":"2019-03-25","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04926818","publication_url":"https://clinicaltrials.gov/study/NCT04926818","title":"A 2-year Randomized, 3-arm, Double-blind, Non-inferiority Study Comparing the Efficacy and Safety of Ofatumumab and Siponimod Versus Fingolimod in Pediatric Patients With Multiple Sclerosis Followed by an Open-label Extension","has_exemption":false,"start_date":"2021-10-05","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05180474","publication_url":"https://clinicaltrials.gov/study/NCT05180474","title":"First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1047 in Subjects With Malignant Solid Tumors","has_exemption":false,"start_date":"2021-12-13","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06267560","publication_url":"https://clinicaltrials.gov/study/NCT06267560","title":"A Randomized Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Pelacarsen (TQJ230) in US Black/African American & Hispanic Patient Populations With Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease","has_exemption":false,"start_date":"2024-04-24","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06525077","publication_url":"https://clinicaltrials.gov/study/NCT06525077","title":"A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Study of the Efficacy and Safety of FT218 in the Treatment of Idiopathic Hypersomnia (IH)","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Avadel","sponsor_slug":"avadel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06664502","publication_url":"https://clinicaltrials.gov/study/NCT06664502","title":"A Phase 1/2a 2-part Study Consisting of an Open-label Multiple Ascending Dose (MAD) Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion (BRVO), and a Dose-finding, Double-masked, Comparative Safety, and Preliminary Efficacy Study of Intravitreal (IVT) EYE201 (Tiespectus) in Participants With Either Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)","has_exemption":false,"start_date":"2024-11-12","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"EyeBiotech Ltd.","sponsor_slug":"eyebiotech-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06983158","publication_url":"https://clinicaltrials.gov/study/NCT06983158","title":"A Phase 1/2a, Open-Label, Multi-Center, Dose-Escalation Trial to Assess Safety, Tolerability, and Efficacy of a Single Dose of CAP-002 Gene Therapy Administered to Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy","has_exemption":false,"start_date":"2025-07-03","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Capsida Biotherapeutics, Inc.","sponsor_slug":"capsida-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07398989","publication_url":"https://clinicaltrials.gov/study/NCT07398989","title":"A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin","has_exemption":false,"start_date":"2025-08-12","completion_date":"2026-03-25","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05732961","publication_url":"https://clinicaltrials.gov/study/NCT05732961","title":"A Phase 2, Single Arm Study of Luspatercept for the Treatment of Anemia in Lower Risk Myelodysplastic Syndromes (MDS) or Non-Proliferative Myelodysplastic Syndromes/ Myeloproliferative Neoplasms (MDS/MPN)","has_exemption":false,"start_date":"2023-02-21","completion_date":"2026-03-26","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05819541","publication_url":"https://clinicaltrials.gov/study/NCT05819541","title":"Dose Escalation Clinical Trial of High-dose Oral Montelukast to Inform Future RCT in Children With Acute Asthma Exacerbations","has_exemption":false,"start_date":"2023-10-20","completion_date":"2026-03-26","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06393907","publication_url":"https://clinicaltrials.gov/study/NCT06393907","title":"A Randomized Trial of Hemostatic Forceps Versus Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers","has_exemption":false,"start_date":"2024-03-26","completion_date":"2026-03-26","has_results":false,"results_due":false,"sponsor_name":"Mahidol University","sponsor_slug":"mahidol-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06881251","publication_url":"https://clinicaltrials.gov/study/NCT06881251","title":"95475939ADM2001: 95475939ADM2001 Ph IIB Trial (N=210)","has_exemption":false,"start_date":"2025-02-26","completion_date":"2026-03-26","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05039515","publication_url":"https://clinicaltrials.gov/study/NCT05039515","title":"A Phase 2 Study to Assess the Efficacy and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva in Male and Female Paediatric and Adult Participants.","has_exemption":false,"start_date":"2021-12-01","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"Clementia Pharmaceuticals Inc.","sponsor_slug":"clementia-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04230148","publication_url":"https://clinicaltrials.gov/study/NCT04230148","title":"A Phase IV, Multi-center, Open-label Study to Determine the Safety, Tolerability and Clinical Outcomes Following Oral Administration of EGATEN™ (Triclabendazole) in Patients (6 Years of Age or Older) With Fascioliasis.","has_exemption":false,"start_date":"2022-02-11","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04895306","publication_url":"https://clinicaltrials.gov/study/NCT04895306","title":"Exploring the Role of Testosterone as a Novel Anti-Nociceptive Agent in Women With Chronic Pain and Opioid Use","has_exemption":false,"start_date":"2022-11-15","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003231","publication_url":"https://clinicaltrials.gov/study/NCT06003231","title":"A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects With Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2","has_exemption":false,"start_date":"2023-11-14","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06299111","publication_url":"https://clinicaltrials.gov/study/NCT06299111","title":"A Master Protocol for a Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of REGN9933 and REGN7508, Monoclonal Antibodies Against Factor XI for Prevention of Venous Thromboembolism in Patients With a Peripherally Inserted Central Catheter (ROXI-CATH)","has_exemption":false,"start_date":"2024-09-20","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06597396","publication_url":"https://clinicaltrials.gov/study/NCT06597396","title":"A Phase 2a Randomized, Dose Ranging, Double-Blind, 3-Arm Study to Investigate Orally Administered Abrocitinib Compared With Placebo in Non-Hospitalized Symptomatic Adult Participants With Severe Fatigue From Post COVID Condition","has_exemption":false,"start_date":"2024-12-27","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07117487","publication_url":"https://clinicaltrials.gov/study/NCT07117487","title":"A Phase 3 Open-label Study to Evaluate Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 at Least 12 Months Following a Primary Dose of a Licensed Protein Subunit RSV Vaccine in Adult Participants ≥60 Years of Age","has_exemption":false,"start_date":"2025-08-05","completion_date":"2026-03-27","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02704858","publication_url":"https://clinicaltrials.gov/study/NCT02704858","title":"An Open-Label, Phase 1/2A Dose Escalation Study of Safety and Efficacy of NEO100 in Recurrent or Progressive Grade III or Grade IV Gliomas With IDH1 Mutation","has_exemption":false,"start_date":"2017-08-01","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Neonc Technologies, Inc.","sponsor_slug":"neonc-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03175224","publication_url":"https://clinicaltrials.gov/study/NCT03175224","title":"Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors","has_exemption":false,"start_date":"2017-09-27","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Apollomics Inc.","sponsor_slug":"apollomics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03173092","publication_url":"https://clinicaltrials.gov/study/NCT03173092","title":"An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) in Patients With Multiple Myeloma Previously Receiving a Bortezomib-Based Induction Regimen (US MM-6)","has_exemption":false,"start_date":"2017-11-13","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04420884","publication_url":"https://clinicaltrials.gov/study/NCT04420884","title":"An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2020-07-22","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04093219","publication_url":"https://clinicaltrials.gov/study/NCT04093219","title":"PANDORA: Scheduled Prophylactic 6-hourly Intravenous Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients","has_exemption":false,"start_date":"2020-08-11","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03668041","publication_url":"https://clinicaltrials.gov/study/NCT03668041","title":"CSP #2016 - National Adaptive Trial for PTSD Related Insomnia","has_exemption":false,"start_date":"2021-02-25","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04620239","publication_url":"https://clinicaltrials.gov/study/NCT04620239","title":"Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (Padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low Grade Upper Tract Urothelial Cancer","has_exemption":false,"start_date":"2021-03-22","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Steba Biotech S.A.","sponsor_slug":"steba-biotech-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04697004","publication_url":"https://clinicaltrials.gov/study/NCT04697004","title":"A Randomized, Multi-Center, Prospective, Safety and Efficacy Study Comparing the Outcome of Total Reverse Shoulder Arthroplasty (RSA) with SMR Stemless Reverse Vs SMR Reverse Shoulder System","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Limacorporate S.p.a","sponsor_slug":"limacorporate-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04214535","publication_url":"https://clinicaltrials.gov/study/NCT04214535","title":"Anterior Cervical Disectomy And Fusion Using The Tritanium® C Anterior Cervical Cage For One Or Two-Levels: A Clinical And Radiographic Analysis Pilot Study","has_exemption":false,"start_date":"2021-05-05","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04979052","publication_url":"https://clinicaltrials.gov/study/NCT04979052","title":"Safety and Efficacy of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Candidemia","has_exemption":false,"start_date":"2022-03-31","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Radboud University Medical Center","sponsor_slug":"radboud-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05230810","publication_url":"https://clinicaltrials.gov/study/NCT05230810","title":"This is a Multicenter, Single Arm, Open-label, run-in Phase Ib / Roll-over Phase II Study of Tucatinib in Combination With Alpelisib in Subjects With PIK3CA-mutant HER2-positive Locally Advanced Unresectable or Metastatic Breast Cancer.","has_exemption":false,"start_date":"2022-08-25","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Criterium, Inc.","sponsor_slug":"criterium-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05211986","publication_url":"https://clinicaltrials.gov/study/NCT05211986","title":"An Open-label Dose Escalation Study to Assess the Safety and Tolerability of IMM01-STEM in Participants With Muscle Atrophy Related to Knee Osteoarthritis","has_exemption":false,"start_date":"2022-09-13","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Immunis, Inc.","sponsor_slug":"immunis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05429268","publication_url":"https://clinicaltrials.gov/study/NCT05429268","title":"A Phase 3, Single-Arm, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma","has_exemption":false,"start_date":"2022-12-23","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05709574","publication_url":"https://clinicaltrials.gov/study/NCT05709574","title":"An Open-Label, Phase II Single-Arm, Window Trial of Tadalafil Effect + Chemotherapy in Patients With Resectable Gastric/GEJ Adenocarcinoma","has_exemption":false,"start_date":"2023-04-20","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05883644","publication_url":"https://clinicaltrials.gov/study/NCT05883644","title":"A Phase IIIb Single Arm, Open-label, Multicentre Study of Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (SIERRA)","has_exemption":false,"start_date":"2023-06-27","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06606925","publication_url":"https://clinicaltrials.gov/study/NCT06606925","title":"Determining Which Regions of the Brain Are Active During Flight Simulation at Separate Timepoints During Training","has_exemption":false,"start_date":"2023-09-19","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"The Geneva Foundation","sponsor_slug":"the-geneva-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05019027","publication_url":"https://clinicaltrials.gov/study/NCT05019027","title":"N-of-1 Trials to Promote Deprescribing in Older Adults With Transthyretin Cardiac Amyloidosis","has_exemption":false,"start_date":"2024-01-31","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05705999","publication_url":"https://clinicaltrials.gov/study/NCT05705999","title":"Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study","has_exemption":false,"start_date":"2024-03-12","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06685068","publication_url":"https://clinicaltrials.gov/study/NCT06685068","title":"A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-11-13","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06815354","publication_url":"https://clinicaltrials.gov/study/NCT06815354","title":"Comprehensive Assessment of Cancer Theranostic Response; Investigating the Intent to Change Treatment Decisions Based on TRAQinform Theranostics","has_exemption":false,"start_date":"2024-12-02","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"AIQ Solutions","sponsor_slug":"aiq-solutions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06591559","publication_url":"https://clinicaltrials.gov/study/NCT06591559","title":"Up, Down, and All Around: Evaluating Mobility Devices for Young Children With Developmental Disabilities and Delays","has_exemption":false,"start_date":"2025-02-11","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06755801","publication_url":"https://clinicaltrials.gov/study/NCT06755801","title":"Microvascular Obstruction Treatment and Outcomes Randomized Study.","has_exemption":false,"start_date":"2025-04-01","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Spanish Society of Cardiology","sponsor_slug":"spanish-society-of-cardiology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07276776","publication_url":"https://clinicaltrials.gov/study/NCT07276776","title":"An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes","has_exemption":false,"start_date":"2025-12-12","completion_date":"2026-03-30","has_results":false,"results_due":false,"sponsor_name":"Insulet Corporation","sponsor_slug":"insulet-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01679132","publication_url":"https://clinicaltrials.gov/study/NCT01679132","title":"BAROSTIM NEO Hypertension Pivotal Trial","has_exemption":false,"start_date":"2013-04-12","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"CVRx, Inc.","sponsor_slug":"cvrx-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01903330","publication_url":"https://clinicaltrials.gov/study/NCT01903330","title":"A Randomized, Double-blinded, Placebo-controlled Study of (ERC1671/GM-CSF/Cyclophosphamide)+Bevacizumab vs. (Placebo Injection/Placebo Pill) +Bevacizumab in the Treatment of Recurrent/Progressive, Bevacizumab naïve Glioblastoma Multiforme and Glioasarcoma Patients (WHO Grade IV Malignant Gliomas, GBM)","has_exemption":false,"start_date":"2014-03-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Epitopoietic Research Corporation","sponsor_slug":"epitopoietic-research-corporation","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03118986","publication_url":"https://clinicaltrials.gov/study/NCT03118986","title":"Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Highly Emetogenic Chemotherapy","has_exemption":false,"start_date":"2017-08-10","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"The Hospital for Sick Children","sponsor_slug":"the-hospital-for-sick-children","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03089905","publication_url":"https://clinicaltrials.gov/study/NCT03089905","title":"Neurodevelopmental Outcome After Standard Dose Sevoflurane Versus Low-dose Sevoflurane/Dexmedetomidine/Remifentanil Anaesthesia in Young Children- The TREX Trial","has_exemption":false,"start_date":"2017-08-10","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Murdoch Childrens Research Institute","sponsor_slug":"murdoch-childrens-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03312972","publication_url":"https://clinicaltrials.gov/study/NCT03312972","title":"F-SHARP: A Phase I/II Trial of Focal Salvage High-dose-rate BRachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy","has_exemption":false,"start_date":"2017-08-28","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Loyola University","sponsor_slug":"loyola-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03292861","publication_url":"https://clinicaltrials.gov/study/NCT03292861","title":"A Pilot Randomized Study to Assess the Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients: A 12-month, Single Center, Randomized, Open-label Study of Efficacy Comparing Immediate Treatment With and Without Thymoglobulin® 1.5 mg/kg/d for 5 Consecutive Days in Heart Transplant Recipients","has_exemption":false,"start_date":"2018-09-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03503305","publication_url":"https://clinicaltrials.gov/study/NCT03503305","title":"Healing Osteoarthritic Joints in the Wrist With Adult Adipose Derived Regenerative Cells","has_exemption":false,"start_date":"2018-11-21","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"InGeneron, Inc.","sponsor_slug":"ingeneron-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03747458","publication_url":"https://clinicaltrials.gov/study/NCT03747458","title":"16-Week Randomized Double-Blind Placebo Controlled Parallel-Group Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day in Adolescents With Bilateral Nasal Polyps Followed With 12-Week Open-Label Treatment Phase","has_exemption":false,"start_date":"2018-12-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Optinose US Inc.","sponsor_slug":"optinose-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03995173","publication_url":"https://clinicaltrials.gov/study/NCT03995173","title":"Brain Targets for Alcohol Craving in Veterans With mTBI","has_exemption":false,"start_date":"2019-03-21","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04201457","publication_url":"https://clinicaltrials.gov/study/NCT04201457","title":"Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine (HCQ) for BRAF V600E-mutant or Trametinib and HCQ for BRAF Fusion/Duplication Positive or NF1-associated Recurrent or Progressive Gliomas in Children and Young Adults","has_exemption":false,"start_date":"2020-01-17","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Pediatric Brain Tumor Consortium","sponsor_slug":"pediatric-brain-tumor-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04259138","publication_url":"https://clinicaltrials.gov/study/NCT04259138","title":"VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target","has_exemption":false,"start_date":"2020-02-18","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Alimentiv Inc.","sponsor_slug":"alimentiv-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04112381","publication_url":"https://clinicaltrials.gov/study/NCT04112381","title":"A Pivotal Clinical Trial to Evaluate the Safety and Efficacy of Staged Bilateral Exablate Treatment of Medication Refractory Essential Tremor","has_exemption":false,"start_date":"2020-06-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"InSightec","sponsor_slug":"insightec","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04561362","publication_url":"https://clinicaltrials.gov/study/NCT04561362","title":"Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies","has_exemption":false,"start_date":"2020-07-17","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"BicycleTx Limited","sponsor_slug":"bicycletx-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04416269","publication_url":"https://clinicaltrials.gov/study/NCT04416269","title":"Use of Oral Antidiabetic Agents in Hospitalized Patients With Diabetes","has_exemption":false,"start_date":"2020-08-07","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04384484","publication_url":"https://clinicaltrials.gov/study/NCT04384484","title":"A Phase 3 Randomized Study of Loncastuximab Tesirine Combined With Rituximab Versus Immunochemotherapy in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-5)","has_exemption":false,"start_date":"2020-09-16","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"ADC Therapeutics S.A.","sponsor_slug":"adc-therapeutics-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04228367","publication_url":"https://clinicaltrials.gov/study/NCT04228367","title":"JuggerStitch™ for Meniscal Repair Post Market Clinical Follow-up Study","has_exemption":false,"start_date":"2020-09-25","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Zimmer Biomet","sponsor_slug":"zimmer-biomet","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04195399","publication_url":"https://clinicaltrials.gov/study/NCT04195399","title":"A Safety, Pharmacokinetic and Efficacy Study of a y-Secretase Inhibitor, Nirogacestat (PF-03084014), in Children and Adolescents With Progressive, Surgically Unresectable Desmoid Tumors","has_exemption":false,"start_date":"2020-10-07","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01590862","publication_url":"https://clinicaltrials.gov/study/NCT01590862","title":"ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain Stimulators","has_exemption":false,"start_date":"2021-01-23","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04763200","publication_url":"https://clinicaltrials.gov/study/NCT04763200","title":"Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial","has_exemption":false,"start_date":"2021-04-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Abiomed Inc.","sponsor_slug":"abiomed-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04836546","publication_url":"https://clinicaltrials.gov/study/NCT04836546","title":"A Post Approval Study to Evaluate the Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System Used Non-adjunctively","has_exemption":false,"start_date":"2021-04-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Senseonics, Inc.","sponsor_slug":"senseonics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04868877","publication_url":"https://clinicaltrials.gov/study/NCT04868877","title":"Phase 1/2 Dose Escalation and Expansion Study Evaluating MCLA-129, a Human Anti-EGFR and Anti-c-MET Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors","has_exemption":false,"start_date":"2021-04-28","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Merus B.V.","sponsor_slug":"merus-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03527537","publication_url":"https://clinicaltrials.gov/study/NCT03527537","title":"Gestational Diabetes and Pharmacotherapy (GAP) - A Randomized Controlled Trial Investigating Timing of Pharmacotherapy Initiation for Patients With Gestational Diabetes","has_exemption":false,"start_date":"2021-05-04","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04550377","publication_url":"https://clinicaltrials.gov/study/NCT04550377","title":"Cannabidiol for Treating PTSD Symptoms and Neurocognitive Impairment in PTSD and PTSD Comorbid With TBI: A Placebo-controlled RCT With Neural-circuit Centered Precision Medicine Prediction of Response.","has_exemption":false,"start_date":"2021-05-26","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05283811","publication_url":"https://clinicaltrials.gov/study/NCT05283811","title":"Mapping Algorithmic State Space in the Human Brain","has_exemption":false,"start_date":"2021-06-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04732962","publication_url":"https://clinicaltrials.gov/study/NCT04732962","title":"The Effect of a Biomechanical Footwear as a Non-invasive Alternative to Total Knee Replacement and as an Additional Rehabilitation Regimen Postoperatively","has_exemption":false,"start_date":"2021-07-22","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Geisinger Clinic","sponsor_slug":"geisinger-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05160129","publication_url":"https://clinicaltrials.gov/study/NCT05160129","title":"Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder","has_exemption":false,"start_date":"2021-08-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05147142","publication_url":"https://clinicaltrials.gov/study/NCT05147142","title":"Low Intensity Focused Ultrasound: a New Paradigm for Depression and Anxiety","has_exemption":false,"start_date":"2021-09-28","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Ocean State Research Institute, Inc.","sponsor_slug":"ocean-state-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04945707","publication_url":"https://clinicaltrials.gov/study/NCT04945707","title":"A Double-blind,Randomized, Placebo-controlled Study to Assess Exercise Tolerance After Iron Repletion With Ferric Derisomaltose (Monoferric®) IV Compared to Placebo in Heart Failure With Preserved Ejection Fraction and With Iron Deficiency.","has_exemption":false,"start_date":"2021-11-26","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05203328","publication_url":"https://clinicaltrials.gov/study/NCT05203328","title":"Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care","has_exemption":false,"start_date":"2022-02-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"The Cooper Health System","sponsor_slug":"the-cooper-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06292026","publication_url":"https://clinicaltrials.gov/study/NCT06292026","title":"A Controlled Data Collection and Prospective Treatment Study to Evaluate the Efficacy of ProgenaMatrix™ in the Management of Diabetic Foot Ulcers","has_exemption":false,"start_date":"2022-03-14","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"ProgenaCare Global, LLC","sponsor_slug":"progenacare-global-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06405074","publication_url":"https://clinicaltrials.gov/study/NCT06405074","title":"Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula","has_exemption":false,"start_date":"2022-04-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Washington D.C. Veterans Affairs Medical Center","sponsor_slug":"washington-dc-veterans-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04743661","publication_url":"https://clinicaltrials.gov/study/NCT04743661","title":"Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients With Recurrent Medulloblastoma and Ependymoma","has_exemption":false,"start_date":"2022-04-04","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Pediatric Brain Tumor Consortium","sponsor_slug":"pediatric-brain-tumor-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05346354","publication_url":"https://clinicaltrials.gov/study/NCT05346354","title":"A Phase 2/3, Open-label, Historical-controlled, Single-arm, Multicenter Study to Evaluate the Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety of Ravulizumab in Children and Adolescents With Aquaporin-4 Antibody Positive (AQP4-Ab [+]) Neuromyelitis Optica Spectrum Disorder (NMOSD)","has_exemption":false,"start_date":"2022-06-23","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05446272","publication_url":"https://clinicaltrials.gov/study/NCT05446272","title":"The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial","has_exemption":false,"start_date":"2022-08-03","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05198323","publication_url":"https://clinicaltrials.gov/study/NCT05198323","title":"A Phase II, Two-Part, Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects With Acute Ischemic Stroke (AIS) Undergoing Endovascular Thrombectomy (EVT)","has_exemption":false,"start_date":"2022-08-11","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Lumosa Therapeutics Co., Ltd.","sponsor_slug":"lumosa-therapeutics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05019885","publication_url":"https://clinicaltrials.gov/study/NCT05019885","title":"A Pilot Study to Assess the Efficacy of Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy","has_exemption":false,"start_date":"2022-08-26","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Madeline Fields","sponsor_slug":"madeline-fields","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05201144","publication_url":"https://clinicaltrials.gov/study/NCT05201144","title":"A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)","has_exemption":false,"start_date":"2022-09-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05530343","publication_url":"https://clinicaltrials.gov/study/NCT05530343","title":"A Multicenter Randomized Trial of Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance (The SWAT-BE Study)","has_exemption":false,"start_date":"2022-10-03","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05583864","publication_url":"https://clinicaltrials.gov/study/NCT05583864","title":"Lumbar Fusion With Porous Titanium Versus Non-Porous Titanium-Coated PEEK Interbody Cages - A Randomized Controlled Trial","has_exemption":false,"start_date":"2022-11-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Francis Farhadi","sponsor_slug":"francis-farhadi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05498272","publication_url":"https://clinicaltrials.gov/study/NCT05498272","title":"A Phase 2 Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations (NePtune)","has_exemption":false,"start_date":"2023-02-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Rana McKay, MD","sponsor_slug":"rana-mckay-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05720039","publication_url":"https://clinicaltrials.gov/study/NCT05720039","title":"A Prospective, Multicenter Randomized Controlled Trial(RCT) of the da Vinci® SP™ Surgical System vs Open Surgery in Nipple Sparing Mastectomy (NSM) Procedures","has_exemption":false,"start_date":"2023-05-08","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Intuitive Surgical","sponsor_slug":"intuitive-surgical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05648591","publication_url":"https://clinicaltrials.gov/study/NCT05648591","title":"Open-label Safety Study of a 1-year 8 to 24 mg/Day Dose Regimen of Iloperidone (FANAPT®) in Adolescent Patients With Schizophrenia or Bipolar I Disorder","has_exemption":false,"start_date":"2023-05-24","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Vanda Pharmaceuticals","sponsor_slug":"vanda-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05993546","publication_url":"https://clinicaltrials.gov/study/NCT05993546","title":"Randomized Controlled Trial of Miniaturized Percutaneous Nephrolithotomy With Vacuum-Assisted Access Sheaths Versus Conventional Sheaths for Treatment of Nephrolithiasis","has_exemption":false,"start_date":"2023-08-29","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05687344","publication_url":"https://clinicaltrials.gov/study/NCT05687344","title":"Intensive Postpartum Antihypertensive Treatment to Improve Women's Cardiovascular Health (IPAT Study)","has_exemption":false,"start_date":"2023-09-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06064812","publication_url":"https://clinicaltrials.gov/study/NCT06064812","title":"A Phase I/II, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Efficacy of FWD1802in Patients With ER+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer","has_exemption":false,"start_date":"2023-09-12","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Forward Pharmaceuticals Co., Ltd.","sponsor_slug":"forward-pharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06067204","publication_url":"https://clinicaltrials.gov/study/NCT06067204","title":"Prehospital Automatic Ventilation on Resuscitation Outcomes in Out-of-hospital Cardiac Arrest Patients: a Randomized Controlled Trial","has_exemption":false,"start_date":"2023-10-02","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"National Taiwan University Hospital","sponsor_slug":"national-taiwan-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06004674","publication_url":"https://clinicaltrials.gov/study/NCT06004674","title":"Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project (UPPPP Trial)","has_exemption":false,"start_date":"2023-12-26","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Endeavor Health","sponsor_slug":"endeavor-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06223880","publication_url":"https://clinicaltrials.gov/study/NCT06223880","title":"A Randomized, Double-blind, Active-controlled Study of AXS-05 for the Prevention of Relapse of Depressive Symptoms","has_exemption":false,"start_date":"2023-12-27","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Axsome Therapeutics, Inc.","sponsor_slug":"axsome-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05704478","publication_url":"https://clinicaltrials.gov/study/NCT05704478","title":"Impact of Vericiguat on Vascular Biology, as Well as Resting and Exertional Cardiovascular Performance Among Patients With Heart Failure With Reduced Ejection Fraction","has_exemption":false,"start_date":"2024-01-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06046833","publication_url":"https://clinicaltrials.gov/study/NCT06046833","title":"Glucose Metrics Using Freestyle Libre 3 Real-Time Continuous Glucose Monitor (rtCGM) in Patients With Gastroparesis in Type 1 or Type 2 Diabetes: Investigator Initiated Pilot Study","has_exemption":false,"start_date":"2024-01-08","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Samita Garg","sponsor_slug":"samita-garg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05780905","publication_url":"https://clinicaltrials.gov/study/NCT05780905","title":"Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes","has_exemption":false,"start_date":"2024-01-11","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06231641","publication_url":"https://clinicaltrials.gov/study/NCT06231641","title":"The Effects of Lemborexant on the Ability to Sleep During Daytime: A Feasibility Study to Evaluate the Potential of Lemborexant to Treat Shift Work Disorder","has_exemption":false,"start_date":"2024-01-11","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal","sponsor_slug":"centre-integre-universitaire-de-sante-et-services-sociaux-du-nord-de-lile-de-montreal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06133101","publication_url":"https://clinicaltrials.gov/study/NCT06133101","title":"Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)","has_exemption":false,"start_date":"2024-01-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Marialena Mouzaki","sponsor_slug":"marialena-mouzaki","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05816265","publication_url":"https://clinicaltrials.gov/study/NCT05816265","title":"Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure With Reduced Ejection Fraction and Iron Deficiency","has_exemption":false,"start_date":"2024-01-24","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Radha Gopalan","sponsor_slug":"radha-gopalan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06200987","publication_url":"https://clinicaltrials.gov/study/NCT06200987","title":"Planned Penile Vibratory Stimulation in the Prevention of Sexual Dysfunction and Urinary Incontinence After Radical Prostatectomy: a Randomized Controlled Study","has_exemption":false,"start_date":"2024-02-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Herlev and Gentofte Hospital","sponsor_slug":"herlev-and-gentofte-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06225843","publication_url":"https://clinicaltrials.gov/study/NCT06225843","title":"A Proof-of-Concept Phase II Trial to Evaluate the EMT Inhibitor Sotevtamab Combined With FOLFOX Administered as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis","has_exemption":false,"start_date":"2024-02-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Alethia Biotherapeutics","sponsor_slug":"alethia-biotherapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06245915","publication_url":"https://clinicaltrials.gov/study/NCT06245915","title":"An Open-label, Multicenter Phase 1/2 Study to Evaluate the Safety and Efficacy of AB-2100 in Patients With Recurrent Advanced or Metastatic Clear-cell Renal Cell Carcinoma (ccRCC)","has_exemption":false,"start_date":"2024-02-26","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Arsenal Biosciences, Inc.","sponsor_slug":"arsenal-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06024473","publication_url":"https://clinicaltrials.gov/study/NCT06024473","title":"A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI","has_exemption":false,"start_date":"2024-03-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Central Arkansas Veterans Healthcare System","sponsor_slug":"central-arkansas-veterans-healthcare-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06309056","publication_url":"https://clinicaltrials.gov/study/NCT06309056","title":"Evaluating the Effectiveness of Neuromuscular Electrical Stimulation for Children With Dysphagia: A Pilot Study","has_exemption":false,"start_date":"2024-03-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Sir Mortimer B. Davis - Jewish General Hospital","sponsor_slug":"sir-mortimer-b-davis-jewish-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06269146","publication_url":"https://clinicaltrials.gov/study/NCT06269146","title":"Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection","has_exemption":false,"start_date":"2024-05-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06382168","publication_url":"https://clinicaltrials.gov/study/NCT06382168","title":"Phase I/II Study of DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia","has_exemption":false,"start_date":"2024-06-12","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Delta-Fly Pharma, Inc.","sponsor_slug":"delta-fly-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06462586","publication_url":"https://clinicaltrials.gov/study/NCT06462586","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Lumateperone in the Acute Treatment of Patients With Manic Episodes or Manic Episodes With Mixed Features Associated With Bipolar I Disorder (Bipolar Mania)","has_exemption":false,"start_date":"2024-06-19","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06425900","publication_url":"https://clinicaltrials.gov/study/NCT06425900","title":"Histologic and Liquid Chromatography Mass Spectrometry (LCMS) Evaluation of the Sebaceous Gland Changes Induced by Clascoterone Cream 1%","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries Limited","sponsor_slug":"sun-pharmaceutical-industries-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06255613","publication_url":"https://clinicaltrials.gov/study/NCT06255613","title":"Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor: Exploring Its Diagnostic Capabilities for Sleep Disordered Breathing With Analysis of Biomarker Dynamics","has_exemption":false,"start_date":"2024-07-19","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Belun Technology Company Limited","sponsor_slug":"belun-technology-company-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06442462","publication_url":"https://clinicaltrials.gov/study/NCT06442462","title":"A Randomized, Placebo-controlled, Double-blind Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacodynamics of SPG302 in Adult Participants Diagnosed With Schizophrenia","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Spinogenix","sponsor_slug":"spinogenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06400303","publication_url":"https://clinicaltrials.gov/study/NCT06400303","title":"KYSA-5: A Phase 1/2, Open-Label, Multicentre Study of KYV 101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis","has_exemption":false,"start_date":"2024-08-06","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Kyverna Therapeutics","sponsor_slug":"kyverna-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06041594","publication_url":"https://clinicaltrials.gov/study/NCT06041594","title":"Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Innova Vascular, Inc.","sponsor_slug":"innova-vascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06457685","publication_url":"https://clinicaltrials.gov/study/NCT06457685","title":"Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Peripheral Artery Disease","has_exemption":false,"start_date":"2024-09-05","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Amplitude Vascular Systems, Inc.","sponsor_slug":"amplitude-vascular-systems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625749","publication_url":"https://clinicaltrials.gov/study/NCT06625749","title":"Early Feasibility Study to Evaluate the Safety and Effectiveness of the AccuraSee™ IOPCL for Secondary Implantation in the Capsular Bag to Improve Near and/or Intermediate Vision Following Previous Cataract Surgery","has_exemption":false,"start_date":"2024-09-23","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"OnPoint Vision Inc","sponsor_slug":"onpoint-vision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06049680","publication_url":"https://clinicaltrials.gov/study/NCT06049680","title":"A Single-arm Open-label Safety Study of SMOFlipid to Evaluate the Risk of Developing Essential Fatty Acid Deficiency (EFAD) and/or Parenteral Nutrition-associated Cholestasis (PNAC) in Pediatric Patients 1 Month to 17 Years of Age and in Adult Patients, Who Are Anticipated to Need 8 Weeks or Longer of Parenteral Nutrition Treatment","has_exemption":false,"start_date":"2024-10-28","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Fresenius Kabi","sponsor_slug":"fresenius-kabi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06473103","publication_url":"https://clinicaltrials.gov/study/NCT06473103","title":"Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy","has_exemption":false,"start_date":"2024-10-29","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05484973","publication_url":"https://clinicaltrials.gov/study/NCT05484973","title":"A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer Stages I-III.","has_exemption":false,"start_date":"2024-11-08","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Cooler Heads Care Inc.","sponsor_slug":"cooler-heads-care-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06374264","publication_url":"https://clinicaltrials.gov/study/NCT06374264","title":"A Single Arm, Prospective, Multi-Center, Feasibility Study to Evaluate the Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder (NMOSD) Who Have an Impaired Gait","has_exemption":false,"start_date":"2024-11-12","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"MedRhythms, Inc.","sponsor_slug":"medrhythms-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06828939","publication_url":"https://clinicaltrials.gov/study/NCT06828939","title":"Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant Pulsed Field Ablation Balloon for the Treatment of Atrial Fibrillation","has_exemption":false,"start_date":"2024-12-12","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"CardioFocus","sponsor_slug":"cardiofocus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06691113","publication_url":"https://clinicaltrials.gov/study/NCT06691113","title":"A Randomized, Double-blind, Placebo-controlled, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of Itepekimab in Participants With Inadequately Controlled Chronic Rhinosinusitis Without Nasal Polyps","has_exemption":false,"start_date":"2024-12-16","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671847","publication_url":"https://clinicaltrials.gov/study/NCT06671847","title":"Feasibility of 24-Weeks of At-Home Chair-Based Resistance Band Training to Improve Balance, Strength, and Bone Density in Older Adults (ChaREx Study)","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06935695","publication_url":"https://clinicaltrials.gov/study/NCT06935695","title":"Surveillance Versus Prn bronChOscoPy aftEr aIrway stenTing (SCOPE-IT)","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06775041","publication_url":"https://clinicaltrials.gov/study/NCT06775041","title":"A Phase 2a, Randomized, Open-Label Study to Determine the Optimal Dose and Evaluate the Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS)","has_exemption":false,"start_date":"2025-01-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"PRG Science & Technology Co., Ltd.","sponsor_slug":"prg-science-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05774665","publication_url":"https://clinicaltrials.gov/study/NCT05774665","title":"Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression","has_exemption":false,"start_date":"2025-01-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06745128","publication_url":"https://clinicaltrials.gov/study/NCT06745128","title":"Tirzepatide for Individuals With Comorbid Obesity and Methamphetamine Use Disorder","has_exemption":false,"start_date":"2025-02-03","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06111209","publication_url":"https://clinicaltrials.gov/study/NCT06111209","title":"A Pilot Study to Evaluate the Anabolic Effect of Testosterone on Muscles of the Pelvic Floor in Older Women With Stress Urinary Incontinence","has_exemption":false,"start_date":"2025-02-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06144749","publication_url":"https://clinicaltrials.gov/study/NCT06144749","title":"An Open Label Phase 2a Ascending Multiple Dose Safety, Efficacy, and Pharmacokinetic Study of HBI-002 Carbon Monoxide Oral Liquid Drug Product in Adolescents and Adults With Sickle Cell Disease.","has_exemption":false,"start_date":"2025-02-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Hillhurst Biopharmaceuticals, Inc.","sponsor_slug":"hillhurst-biopharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05790239","publication_url":"https://clinicaltrials.gov/study/NCT05790239","title":"A Randomized, Double-Blind, Single-Site Phase II 2-Arm Study to Compare the Safety and Preliminary Efficacy of Manualized MDMA-Assisted Therapy to Low Dose D-Amphetamine Assisted Therapy in Veterans For The Treatment of Moderate to Severe PTSD","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Stephen Robert Marder","sponsor_slug":"stephen-robert-marder","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06839833","publication_url":"https://clinicaltrials.gov/study/NCT06839833","title":"A Prospective, Interventional Study to Assess the Clinical Performance of the APOL1 Genotyping Clinical Trial Assay in the Intended Use Population and Environment","has_exemption":false,"start_date":"2025-03-06","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Almac Diagnostic Services LLC","sponsor_slug":"almac-diagnostic-services-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06578624","publication_url":"https://clinicaltrials.gov/study/NCT06578624","title":"A Phase 1/2a, Open-Label Study of Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SA53-OS, an MDM2 Inhibitor, in Patients With Locally Advanced or Metastatic p53 Wild-Type Solid Tumors","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Lamassu Bio Inc","sponsor_slug":"lamassu-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06885073","publication_url":"https://clinicaltrials.gov/study/NCT06885073","title":"Non-invasive Central Venous Pressure Estimation in Pediatric Patients","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Compremium AG","sponsor_slug":"compremium-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07264205","publication_url":"https://clinicaltrials.gov/study/NCT07264205","title":"Safety and Feasibility Study of RT-310 for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)","has_exemption":false,"start_date":"2025-03-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Resurge Therapeutics Inc.","sponsor_slug":"resurge-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06903767","publication_url":"https://clinicaltrials.gov/study/NCT06903767","title":"Do Quantifiable Differences in Physiologic Stress Exist in Surgeons When Comparing the Use of a Powered Femoral Impactor Versus Manual Impaction in Total Hip Arthroplasty?","has_exemption":false,"start_date":"2025-03-25","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Rothman Institute Orthopaedics","sponsor_slug":"rothman-institute-orthopaedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06872801","publication_url":"https://clinicaltrials.gov/study/NCT06872801","title":"Comparison of the Effects of Home High-Flow Nasal Cannula Therapy and Noninvasive Ventilation in Patients With Stable Chronic Hypercapnic Respiratory Failure","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Wonju Severance Christian Hospital","sponsor_slug":"wonju-severance-christian-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06664775","publication_url":"https://clinicaltrials.gov/study/NCT06664775","title":"An Open Label, Prospective, Randomized, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of TachoSil® Versus Surgicel™ Original (Oxidized Regenerated Cellulose) as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery.","has_exemption":false,"start_date":"2025-04-02","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Corza Medical GmbH","sponsor_slug":"corza-medical-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06747468","publication_url":"https://clinicaltrials.gov/study/NCT06747468","title":"A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Avexitide in Participants With Post-Bariatric Hypoglycemia","has_exemption":false,"start_date":"2025-04-29","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Amylyx Pharmaceuticals Inc.","sponsor_slug":"amylyx-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06831422","publication_url":"https://clinicaltrials.gov/study/NCT06831422","title":"Application of a Novel Antimicrobial Wash Versus Hydrogen Peroxide Versus Povidone-iodine to the Dermis and Incidence of Cutibacterium Acnes During Shoulder Arthroplasty: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-05-05","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223632","publication_url":"https://clinicaltrials.gov/study/NCT07223632","title":"The Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient With Confirmed IGHMBP2 Intronic Cryptic Splice Variant C. 1235+894C>A That is Amenable to Antisense Oligonucleotide (ASO)-Mediated Correction of IGHMBP2 Splicing","has_exemption":false,"start_date":"2025-05-13","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Vanda Pharmaceuticals","sponsor_slug":"vanda-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07041073","publication_url":"https://clinicaltrials.gov/study/NCT07041073","title":"Restoring Emotional Stability Through Neurofeedback and AI for Transformative Empowerment","has_exemption":false,"start_date":"2025-05-19","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Corporacion Parc Tauli","sponsor_slug":"corporacion-parc-tauli","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07047209","publication_url":"https://clinicaltrials.gov/study/NCT07047209","title":"A Phase 2a Biomarker-Driven Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS) - The Acacia Trial, an ALS MyMatch Trial","has_exemption":false,"start_date":"2025-05-27","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222280","publication_url":"https://clinicaltrials.gov/study/NCT07222280","title":"Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy","has_exemption":false,"start_date":"2025-06-10","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Covenant Health, US","sponsor_slug":"covenant-health-us","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06998043","publication_url":"https://clinicaltrials.gov/study/NCT06998043","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects With Chronic Pseudomonas Aeruginosa (PsA) Pulmonary Infection","has_exemption":false,"start_date":"2025-07-02","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"BiomX Ltd","sponsor_slug":"biomx-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06798675","publication_url":"https://clinicaltrials.gov/study/NCT06798675","title":"A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE-RANGING CLINICAL TRIAL TO EVALUATE THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF nC-001 IN PATIENTS WITH CHRONIC EUVOLEMIC HYPONATREMIA","has_exemption":false,"start_date":"2025-08-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"nephCentric","sponsor_slug":"nephcentric","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06591091","publication_url":"https://clinicaltrials.gov/study/NCT06591091","title":"Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07090811","publication_url":"https://clinicaltrials.gov/study/NCT07090811","title":"Streamlined One-wire Logistics Optimize Transcatheter Aortic Valve Replacement","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Solo Pace, Inc.","sponsor_slug":"solo-pace-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096934","publication_url":"https://clinicaltrials.gov/study/NCT07096934","title":"A Prospective, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"FibroBiologics","sponsor_slug":"fibrobiologics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07124130","publication_url":"https://clinicaltrials.gov/study/NCT07124130","title":"Parenteral Lactated Ringer's Plus Dextrose 5% vs Lactated Ringer's in Labor: A Randomized Control Trial on Maternal and Neonatal Outcomes","has_exemption":false,"start_date":"2025-09-30","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Eastern Virginia Medical School","sponsor_slug":"eastern-virginia-medical-school","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05621538","publication_url":"https://clinicaltrials.gov/study/NCT05621538","title":"A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Auburn University","sponsor_slug":"auburn-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07205120","publication_url":"https://clinicaltrials.gov/study/NCT07205120","title":"Fluid Guided Heart Failure Treatment","has_exemption":false,"start_date":"2025-10-08","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Bodyport Inc.","sponsor_slug":"bodyport-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07189013","publication_url":"https://clinicaltrials.gov/study/NCT07189013","title":"Assessing Patient Preference for Infusion Systems (Electronic vs. Mechanical)","has_exemption":false,"start_date":"2025-10-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"KORU Medical Systems, Inc.","sponsor_slug":"koru-medical-systems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07085416","publication_url":"https://clinicaltrials.gov/study/NCT07085416","title":"Sensor Ankle Brace for Special Operations Rehabilitation","has_exemption":false,"start_date":"2025-10-16","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209163","publication_url":"https://clinicaltrials.gov/study/NCT07209163","title":"An Open-label, Single-arm Study Evaluating the Safety and Efficacy of Tazemetostat in Combination With Linperlisib/Golidocitinib in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma","has_exemption":false,"start_date":"2025-10-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Ruijin Hospital","sponsor_slug":"ruijin-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07210697","publication_url":"https://clinicaltrials.gov/study/NCT07210697","title":"Orthodontic Pain Alleviation With Chewing Gum","has_exemption":false,"start_date":"2025-10-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212803","publication_url":"https://clinicaltrials.gov/study/NCT07212803","title":"Evaluation of Energy Drinks on Electrocardiographic Parameters: A Randomized, Double Blind, Controlled, Crossover, Proof-of-concept Study","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"University of the Pacific","sponsor_slug":"university-of-the-pacific","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228325","publication_url":"https://clinicaltrials.gov/study/NCT07228325","title":"A Comparison of PK and PD Responses Following Single and Repeat Administration of Epinephrine Nasal FMXIN002 4.0 mg and EpiPen 0.3 mg, in Healthy Adults With Allergic Rhinitis","has_exemption":false,"start_date":"2025-11-03","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Nasus Pharma","sponsor_slug":"nasus-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07393334","publication_url":"https://clinicaltrials.gov/study/NCT07393334","title":"Effects of NLS-133, a Potential Non-Hormonal \"On-Demand\" Male Contraceptive, on Semen Volume and Sperm Count in Normal Men: A Double-Blind, Placebo-Controlled Trial","has_exemption":false,"start_date":"2025-12-02","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Next Life Sciences","sponsor_slug":"next-life-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07296419","publication_url":"https://clinicaltrials.gov/study/NCT07296419","title":"Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems","has_exemption":false,"start_date":"2025-12-08","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Raydiant Oximetry, Inc.","sponsor_slug":"raydiant-oximetry-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321938","publication_url":"https://clinicaltrials.gov/study/NCT07321938","title":"Accuracy Evaluation of the Owlet OSS 3.0-M1 Sensor in Toddlers and Preschoolers","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Owlet Baby Care, Inc.","sponsor_slug":"owlet-baby-care-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07021729","publication_url":"https://clinicaltrials.gov/study/NCT07021729","title":"Comparison of Conventional Clarithromycin Vs Alternative Levofloxacin Based Regimen in Treatment of Helicobacter Pylori Infection","has_exemption":false,"start_date":"2025-12-31","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Rehman Medical Institute - RMI","sponsor_slug":"rehman-medical-institute-rmi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07369180","publication_url":"https://clinicaltrials.gov/study/NCT07369180","title":"Safety and Efficacy of an Accelerated, Rectangular Waveform rTMS Protocol in Treatment of Adults With Major Depressive Disorder.","has_exemption":false,"start_date":"2026-01-15","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"NeuroQore Inc.","sponsor_slug":"neuroqore-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07397078","publication_url":"https://clinicaltrials.gov/study/NCT07397078","title":"Moni-Patch Temperature Monitoring Patch System Clinical Accuracy Validation","has_exemption":false,"start_date":"2026-01-21","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Murata Vios, Inc.","sponsor_slug":"murata-vios-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06723171","publication_url":"https://clinicaltrials.gov/study/NCT06723171","title":"A 4-Week, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of the RXR Agonist Compound IRX4204 for the Treatment of Mild to Moderate Plaque Psoriasis","has_exemption":false,"start_date":"2026-03-01","completion_date":"2026-03-31","has_results":false,"results_due":false,"sponsor_name":"Io Therapeutics","sponsor_slug":"io-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03471117","publication_url":"https://clinicaltrials.gov/study/NCT03471117","title":"Targeting ADMA With Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients","has_exemption":false,"start_date":"2018-04-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Arlington","sponsor_slug":"the-university-of-texas-at-arlington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03400215","publication_url":"https://clinicaltrials.gov/study/NCT03400215","title":"Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer","has_exemption":false,"start_date":"2018-07-23","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03809533","publication_url":"https://clinicaltrials.gov/study/NCT03809533","title":"Transplantation of Kidneys of Hepatitis C (HCV) Seropositive Donors to HCV Seronegative Recipients With Subsequent Therapy With Sofosbuvir/Velpatasvir (Epclusa)","has_exemption":false,"start_date":"2019-05-29","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Amit D Tevar, MD","sponsor_slug":"amit-d-tevar-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04065438","publication_url":"https://clinicaltrials.gov/study/NCT04065438","title":"Treatment of Drug-resistant Adult and Pediatrc Primary Focal Segmental Glomerulosclerosis and Post -Transplant Recurrence Using the LIPOSORBER® LA-15 System","has_exemption":false,"start_date":"2020-01-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Kaneka Medical America LLC","sponsor_slug":"kaneka-medical-america-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04315571","publication_url":"https://clinicaltrials.gov/study/NCT04315571","title":"Effective Ascites ReLief In earlY TIPS (EARLY TIPS) Using Viatorr CX vs. LVP Study","has_exemption":false,"start_date":"2020-03-24","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04278768","publication_url":"https://clinicaltrials.gov/study/NCT04278768","title":"A Phase 1/2A, Open Label Dose Escalation and Expansion Study of Orally Administered CA-4948 as a Monotherapy in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome","has_exemption":false,"start_date":"2020-07-06","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Curis, Inc.","sponsor_slug":"curis-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04899310","publication_url":"https://clinicaltrials.gov/study/NCT04899310","title":"A Global Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency","has_exemption":false,"start_date":"2021-08-06","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04812366","publication_url":"https://clinicaltrials.gov/study/NCT04812366","title":"Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer","has_exemption":false,"start_date":"2021-09-21","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of British Columbia","sponsor_slug":"university-of-british-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04724447","publication_url":"https://clinicaltrials.gov/study/NCT04724447","title":"EXPERIMENTAL ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION: AFFECTIVE, NEURAL, AND INFLAMMATORY MECHANISMS","has_exemption":false,"start_date":"2021-11-23","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Laureate Institute for Brain Research, Inc.","sponsor_slug":"laureate-institute-for-brain-research-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05388123","publication_url":"https://clinicaltrials.gov/study/NCT05388123","title":"A Single Arm Phase II Pilot Study of Low Dose Vemurafenib Plus Rituximab in the Front-line and Relapsed/Refractory Treatment of Hairy Cell Leukemia","has_exemption":false,"start_date":"2022-03-02","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Scripps Health","sponsor_slug":"scripps-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04460521","publication_url":"https://clinicaltrials.gov/study/NCT04460521","title":"The Use of N-acetylcysteine Supplementation in Addition to Night Splinting for Treatment of Mild to Moderate Carpal Tunnel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial","has_exemption":false,"start_date":"2022-04-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Emily Krauss","sponsor_slug":"emily-krauss","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05898087","publication_url":"https://clinicaltrials.gov/study/NCT05898087","title":"Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty","has_exemption":false,"start_date":"2022-04-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Connecticut Children's Medical Center","sponsor_slug":"connecticut-childrens-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05443685","publication_url":"https://clinicaltrials.gov/study/NCT05443685","title":"An Open-Label, Phase 1/2, Single-Site Study of the Safety, Biochemical Efficacy, and Exploratory Clinical Effects of Oral ADX-629 in Subjects With Sjögren-Larsson Syndrome","has_exemption":false,"start_date":"2023-01-02","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05561725","publication_url":"https://clinicaltrials.gov/study/NCT05561725","title":"The Impact of Perioperative Steroid Dosing on the Acute Phase Response in Adolescent Idiopathic Scoliosis","has_exemption":false,"start_date":"2023-01-03","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05649722","publication_url":"https://clinicaltrials.gov/study/NCT05649722","title":"An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease","has_exemption":false,"start_date":"2023-05-11","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06064890","publication_url":"https://clinicaltrials.gov/study/NCT06064890","title":"A Phase 1/2 Open-Label, Ascending Dose, Multicenter Study to Evaluate the Safety and Preliminary Efficacy of AVB-101 Administered by Bilateral Intrathalamic Infusion in Subjects With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)","has_exemption":false,"start_date":"2023-08-30","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"AviadoBio Ltd","sponsor_slug":"aviadobio-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05555056","publication_url":"https://clinicaltrials.gov/study/NCT05555056","title":"Enhancing the Effectiveness of Cognitive Behavioral Therapy Using Non-invasive Brain Stimulation","has_exemption":false,"start_date":"2023-09-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Manitoba","sponsor_slug":"university-of-manitoba","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05683834","publication_url":"https://clinicaltrials.gov/study/NCT05683834","title":"A Phase 1/2 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-Seronegative Persons","has_exemption":false,"start_date":"2023-09-22","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06062446","publication_url":"https://clinicaltrials.gov/study/NCT06062446","title":"A Prospective, Single-Arm Study of a Modified Lumbar Puncture (LP) Procedure That Reduces Post-Lumbar Puncture Headaches (PLPH) in Adult Patients","has_exemption":false,"start_date":"2023-11-08","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06167733","publication_url":"https://clinicaltrials.gov/study/NCT06167733","title":"Safety and Efficacy Assessment of the VERTICA® - a Radio Frequency Device for the Treatment of Erectile Dysfunction","has_exemption":false,"start_date":"2023-11-29","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"OHH-MED Medical Ltd","sponsor_slug":"ohh-med-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06033586","publication_url":"https://clinicaltrials.gov/study/NCT06033586","title":"An Extension Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera (THRIVE)","has_exemption":false,"start_date":"2024-01-22","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Protagonist Therapeutics, Inc.","sponsor_slug":"protagonist-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06208150","publication_url":"https://clinicaltrials.gov/study/NCT06208150","title":"64407564MMY3009: A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investigator's Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pom","has_exemption":false,"start_date":"2024-01-22","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06034938","publication_url":"https://clinicaltrials.gov/study/NCT06034938","title":"DOR/TDF/3TC Maintenance Therapy Among Patients Harboring M184V/I Mutation: a Pilot Open-label Study","has_exemption":false,"start_date":"2024-02-08","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Caen","sponsor_slug":"university-hospital-caen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06347497","publication_url":"https://clinicaltrials.gov/study/NCT06347497","title":"Safety and Efficacy of Zonisamide Versus Topiramate in Migraine","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06619301","publication_url":"https://clinicaltrials.gov/study/NCT06619301","title":"Randomized Controlled Trial of Glargine Versus Neutral Protamine Hagedorn Insulin for the Treatment of Diabetes Mellitus in Pregnancy","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Loyola University","sponsor_slug":"loyola-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06351683","publication_url":"https://clinicaltrials.gov/study/NCT06351683","title":"Mito-LUTS: A Pilot Study of the Effect of MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome","has_exemption":false,"start_date":"2024-04-03","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Iman Al-Naggar, PhD","sponsor_slug":"iman-al-naggar-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06239818","publication_url":"https://clinicaltrials.gov/study/NCT06239818","title":"Assessing the Effects of Photobiomodulation on Clinical Recovery From Concussion in Adolescents","has_exemption":false,"start_date":"2024-04-17","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06314061","publication_url":"https://clinicaltrials.gov/study/NCT06314061","title":"The Effect of Continuous Glucose Monitoring With Real-time Alerts on Glycaemic Control in Surgical Patients With Diabetes: A Randomised, Clinical Multicentre Trial","has_exemption":false,"start_date":"2024-06-24","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Christian S. Meyhoff","sponsor_slug":"christian-s-meyhoff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736964","publication_url":"https://clinicaltrials.gov/study/NCT06736964","title":"Clinical Evaluation of Different Bioactive Restorative Materials for Cervical Carious in High Caries Risk Patients :A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06218030","publication_url":"https://clinicaltrials.gov/study/NCT06218030","title":"PSIY-744-23: Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study","has_exemption":false,"start_date":"2024-10-22","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Queen's University","sponsor_slug":"queens-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06694077","publication_url":"https://clinicaltrials.gov/study/NCT06694077","title":"Comparative Study of Dexamethasone Plus Bupivacaine Versus Bupivacaine in Suprazygomatic Maxillary Nerve Block for Management of Postoperative Pain in Adenotonsillectomy Patients","has_exemption":false,"start_date":"2024-12-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06938867","publication_url":"https://clinicaltrials.gov/study/NCT06938867","title":"A Phase 1b/2a, Randomized, Double-blind Study to Investigate Safety, Tolerability, PK, PD, and Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplantation Receiving Fluoroquinolone Prophylaxis and Harboring Fluoroquinolone-Resistant Escherichia Coli Pre-Transplant","has_exemption":false,"start_date":"2025-02-25","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"SNIPR Biome Aps.","sponsor_slug":"snipr-biome-aps","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07046806","publication_url":"https://clinicaltrials.gov/study/NCT07046806","title":"Oral Deucrictibant for the Prophylactic and Acute Treatment in Patients With Bradykinin Mediated Angioedema With Normal C1 Inhibitor (BK-AE-nC1INH)","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Institute for Asthma and Allergy","sponsor_slug":"institute-for-asthma-and-allergy","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06692907","publication_url":"https://clinicaltrials.gov/study/NCT06692907","title":"A Phase 2b, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Intramuscularly Administered CssBA+dmLT Against Moderate-severe Diarrhea in a Controlled Human Infection Model With Enterotoxigenic Escherichia Coli (ETEC) Strain B7A in Healthy Adults","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06809725","publication_url":"https://clinicaltrials.gov/study/NCT06809725","title":"Validation of the SPARK Scan Cognitive Status Indicator Software Concordance With Clinical Diagnosis in Humans With Unimpaired, Mild Cognitive Impairment and Dementia Status, With and Without Alzheimer's Disease","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Spark Neuro Inc.","sponsor_slug":"spark-neuro-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06874101","publication_url":"https://clinicaltrials.gov/study/NCT06874101","title":"Evaluating a Respiratory Oxygen Adherence Monitor for COPD Patients With Long-term Oxygen Therapy","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Barron Associates, Inc.","sponsor_slug":"barron-associates-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06883123","publication_url":"https://clinicaltrials.gov/study/NCT06883123","title":"Efficacy and Tolerability of Simbrinza and Rocklatan vs. Cosopt","has_exemption":false,"start_date":"2025-05-14","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Prairie Eye Center","sponsor_slug":"prairie-eye-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06933381","publication_url":"https://clinicaltrials.gov/study/NCT06933381","title":"Topical Vapocoolant to Reduce Pain With Nexplanon Insertion: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-06-16","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Queen's Medical Center","sponsor_slug":"queens-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06986824","publication_url":"https://clinicaltrials.gov/study/NCT06986824","title":"A Pilot Study To Assess The Effect Of Antepartum Perineal Massage Using A Pelvic Wand On Labor Agency And Pelvic Health","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07461389","publication_url":"https://clinicaltrials.gov/study/NCT07461389","title":"Effects of Pre-procedure and Intra-procedure Simethicone and Dicyclomine Administration in Improving Quality of Endoscopic Reterograde Cholangipancreaticography (ERCP)","has_exemption":false,"start_date":"2025-10-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"CMH Lahore Medical College and Institute of Dentistry","sponsor_slug":"cmh-lahore-medical-college-and-institute-of-dentistry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06023043","publication_url":"https://clinicaltrials.gov/study/NCT06023043","title":"A Randomized Trial of Postoperative Steroid Use Following Posterior Spinal Fusion in 100-subject Adolescent Idiopathic Scoliosis (AIS) and Neuromuscular Scoliosis (NMS)","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Los Angeles","sponsor_slug":"childrens-hospital-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217639","publication_url":"https://clinicaltrials.gov/study/NCT07217639","title":"Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings","has_exemption":false,"start_date":"2025-11-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Aptitude Medical Systems","sponsor_slug":"aptitude-medical-systems","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07132177","publication_url":"https://clinicaltrials.gov/study/NCT07132177","title":"Targeted Naltrexone to Support Individuals Participating in Dry January","has_exemption":false,"start_date":"2025-11-03","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222722","publication_url":"https://clinicaltrials.gov/study/NCT07222722","title":"Near Infrared Spectroscopy (NIRS) Monitoring as an Early Predictor of Acute Kidney Injury (AKI) in a Vulnerable Neonatal Intensive Care Unit (NICU) Population","has_exemption":false,"start_date":"2025-11-30","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07267299","publication_url":"https://clinicaltrials.gov/study/NCT07267299","title":"Efficacy of Switching Participants Treated With Restasis to TRYPTYR","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-04-01","has_results":false,"results_due":false,"sponsor_name":"Southern College of Optometry","sponsor_slug":"southern-college-of-optometry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05517447","publication_url":"https://clinicaltrials.gov/study/NCT05517447","title":"An Open-label Extension Study for Participants Who Completed Study IMVT-1401-3201 or Study IMVT-1401-3202 to Assess the Efficacy and Safety of Batoclimab for the Treatment of Thyroid Eye Disease (TED)","has_exemption":false,"start_date":"2022-11-06","completion_date":"2026-04-02","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05819359","publication_url":"https://clinicaltrials.gov/study/NCT05819359","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson's Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene","has_exemption":false,"start_date":"2023-03-31","completion_date":"2026-04-02","has_results":false,"results_due":false,"sponsor_name":"Bial R&D Investments, S.A.","sponsor_slug":"bial-rd-investments-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06172257","publication_url":"https://clinicaltrials.gov/study/NCT06172257","title":"A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS 01 Eye Drops in Subjects With Diabetic Macular Edema","has_exemption":false,"start_date":"2024-03-15","completion_date":"2026-04-02","has_results":false,"results_due":false,"sponsor_name":"Oculis","sponsor_slug":"oculis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03250338","publication_url":"https://clinicaltrials.gov/study/NCT03250338","title":"Phase III Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of the Addition of Crenolanib to Salvage Chemotherapy Versus Salvage Chemotherapy Alone in Subjects ≤ 75 Years of Age With Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia","has_exemption":false,"start_date":"2018-08-16","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Arog Pharmaceuticals, Inc.","sponsor_slug":"arog-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04384692","publication_url":"https://clinicaltrials.gov/study/NCT04384692","title":"Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis","has_exemption":false,"start_date":"2020-12-18","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05237388","publication_url":"https://clinicaltrials.gov/study/NCT05237388","title":"Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease","has_exemption":false,"start_date":"2023-04-20","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06695130","publication_url":"https://clinicaltrials.gov/study/NCT06695130","title":"A Phase 1/2, Parallel, Randomized, Modified Double-blind, Multi-arm Study to Assess the Safety and Immunogenicity of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older","has_exemption":false,"start_date":"2024-11-18","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06702878","publication_url":"https://clinicaltrials.gov/study/NCT06702878","title":"A Group-Randomized, Standard-of-Care-Controlled, Crossover Trial Evaluating Nasal Antimicrobial Photodisinfection for the Prevention of Surgical Site Infections","has_exemption":false,"start_date":"2024-12-27","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"Ondine Biomedical Inc.","sponsor_slug":"ondine-biomedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06794866","publication_url":"https://clinicaltrials.gov/study/NCT06794866","title":"A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OnabotulinumtoxinA Purified Neurotoxin Complex for the Treatment of Moderate to Severe Forehead Lines in Japan","has_exemption":false,"start_date":"2025-01-22","completion_date":"2026-04-03","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05712356","publication_url":"https://clinicaltrials.gov/study/NCT05712356","title":"A Phase 2a, Double-blind, Placebo-controlled, Multi-center, Randomized Study Evaluating LSTA1 When Added to Standard of Care (SoC) Versus Standard of Care Alone in Subjects With Advanced Solid Tumors (BOLSTER)","has_exemption":false,"start_date":"2023-05-13","completion_date":"2026-04-05","has_results":true,"results_due":false,"sponsor_name":"Lisata Therapeutics, Inc.","sponsor_slug":"lisata-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT07387380","publication_url":"https://clinicaltrials.gov/study/NCT07387380","title":"KIRA Uterine Drain Device Evaluation - First-In- Human Study","has_exemption":false,"start_date":"2026-01-06","completion_date":"2026-04-05","has_results":false,"results_due":false,"sponsor_name":"Lucie Medical Inc","sponsor_slug":"lucie-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03258931","publication_url":"https://clinicaltrials.gov/study/NCT03258931","title":"Phase III Randomized Study of Crenolanib Versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects With FLT3 Mutated Acute Myeloid Leukemia","has_exemption":false,"start_date":"2018-08-15","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Arog Pharmaceuticals, Inc.","sponsor_slug":"arog-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05341544","publication_url":"https://clinicaltrials.gov/study/NCT05341544","title":"Non-invasive Vagal Stimulation for Frequent Premature Ventricular Complexes (NoVa-PVC)","has_exemption":false,"start_date":"2022-08-22","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05350150","publication_url":"https://clinicaltrials.gov/study/NCT05350150","title":"Non-invasive Vagus Nerve Stimulation in Patients Undergoing Electrophysiological Study (VNS-EPS)","has_exemption":false,"start_date":"2022-08-22","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05864846","publication_url":"https://clinicaltrials.gov/study/NCT05864846","title":"A Phase 4, Interventional, Multicenter, Open-Label, Single-Arm Study to Assess Behavioral and Other Co-occurring Outcomes Following Treatment With EPID(I/Y)OLEX as Add-on Therapy in Participants (Aged 1 to 65 Years Old) With Seizures Associated With Tuberous Sclerosis Complex","has_exemption":false,"start_date":"2023-06-29","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05929066","publication_url":"https://clinicaltrials.gov/study/NCT05929066","title":"A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (TRIUMPH-1)","has_exemption":false,"start_date":"2023-07-10","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07082816","publication_url":"https://clinicaltrials.gov/study/NCT07082816","title":"A Phase III, Prospective, Double-Masked, Randomized, Multi-Center, Active-Controlled, Parallel Group Comparison Study Assessing the Ocular Hypotensive Efficacy of Reformulated PG324 Ophthalmic Solution in Subjects With Elevated Intraocular Pressure","has_exemption":false,"start_date":"2025-09-02","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07280286","publication_url":"https://clinicaltrials.gov/study/NCT07280286","title":"Incidence of Intrauterine Adhesions Following Myomectomies With the Use of an Intrauterine Anti-adhesion Gel","has_exemption":false,"start_date":"2025-12-09","completion_date":"2026-04-06","has_results":false,"results_due":false,"sponsor_name":"Federico II University","sponsor_slug":"federico-ii-university","status":"ongoing","is_pact":false,"days_late":null}]}